Does the tumor necrosis factor a predictor factor in patients with chronic hepatitis B and C

Bilgic Y., Seckin Y., Cagin Y. F., Yildirim O., Yilmaz C., Harputluoglu M., ...Daha Fazla

BIOMEDICAL RESEARCH-INDIA, cilt.28, sa.4, ss.1683-1688, 2017 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 4
  • Basım Tarihi: 2017
  • Dergi Adı: BIOMEDICAL RESEARCH-INDIA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Chemical Abstracts Core
  • Sayfa Sayıları: ss.1683-1688
  • Anahtar Kelimeler: Hepatitis B, Hepatitis C, TNF alpha, Lamuvidin, Pegile interferon, VIRUS-INFECTION, FACTOR-ALPHA, PROMOTER POLYMORPHISM, VIRAL-HEPATITIS, GENE-EXPRESSION, HCV INFECTION, INTERFERON, DISEASE, LIVER, HEPATOCYTES
  • İnönü Üniversitesi Adresli: Evet

Özet

Aim: In our research, we aimed to investigate the importance and pattern of Tumor Necrosis Factor (TNF) alpha in response to the combinatorial treatment of lamuvidin (LAM) and Pegile interferon (PEG INF) 2a + Ribavirin (RIB) in patients with Chronic Hepatitis B (CHB) and Chronic Hepatitis C (CHC).